Previous close | 43.74 |
Open | 44.16 |
Bid | 45.38 x 100 |
Ask | 45.51 x 100 |
Day's range | 43.88 - 45.72 |
52-week range | 29.24 - 53.05 |
Volume | |
Avg. volume | 449,487 |
Market cap | 2.196B |
Beta (5Y monthly) | 1.73 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.07 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.90 |
With the business potentially at an important milestone, we thought we'd take a closer look at Vericel Corporation's...
Director ZERBE ROBERT L MD has sold 3,278 shares of Vericel Corp (NASDAQ:VCEL) on March 27, 2024, according to a recent SEC filing.
This land developer stock hit a new high and is in a buy zone. A burn treatment biotech stock reached a high and gained 47% this year.